Revolution Medicines
NASDAQ: RVMDRedwood City, US · Founded 2014 · Delaware corporation · 4 known investors
Founders & leadership
MH
Margaret HornExecutive
MA
Mark A. GoldsmithinCEO and President
Board
LL
Laurence LaskyBoard director
AB
Alexis BorisyBoard directorChairman at Nextech Invest
EA
Elizabeth AndersonBoard director
MB
Michael BonneyBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$204.2M disclosed across 3 rounds · 2014–2019
▶$100.3MraisedNov 2019 · 34 investors · PharmaceuticalsRule 506(b)
▶$100.3MraisedNov 2019 · 34 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alexis BorisyDirector
- Barbara WeberDirector
- Thilo SchroederDirector
- Vincent MillerDirector
- Laurence LaskyDirector
- Neil ExterDirector
- Mark A. GoldsmithExecutive Officer, Director
- Margaret HornExecutive Officer
- Elizabeth AndersonDirector
- Steve KelseyExecutive Officer
- Offering amount
- $100.3M
- Amount sold
- $100.3M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$56.4MraisedJul 2018 · 18 investors · PharmaceuticalsRule 506(b)
▶$56.4MraisedJul 2018 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Laurence LaskyDirector
- Steve KelseyExecutive Officer
- Barbara WeberDirector
- Margaret HornExecutive Officer
- Thilo SchroederDirector
- Alexis BorisyDirector
- Vincent MillerDirector
- Luan WilfongExecutive Officer
- Elizabeth AndersonDirector
- Mark A. GoldsmithExecutive Officer, Director
- Ryan MartinsExecutive Officer
- Offering amount
- $56.4M
- Amount sold
- $56.4M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$47.5MraisedDec 2016 · 4 investors · PharmaceuticalsRule 506(b)
▶$47.5MraisedDec 2016 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Laurence LaskyDirector
- Alexis BorisyDirector
- Margaret HornExecutive Officer
- Michael BonneyDirector
- Mark A. GoldsmithExecutive Officer, Director
- Elizabeth AndersonDirector
- Offering amount
- $70M
- Amount sold
- $47.5M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Revolution Medicines's investors?
- Revolution Medicines's investors include Bain Capital Life Sciences, Foresite Capital, Nextech Invest, Third Rock Ventures.
- How much funding has Revolution Medicines raised?
- Revolution Medicines has disclosed $204.2M raised across 3 rounds.
- Where is Revolution Medicines headquartered?
- Revolution Medicines is headquartered in Redwood City, US.